MetaCap

Covista Inc. (CVSA)

NYSE: CVSAReal EstateOther Consumer ServicesUSD

127.30-0.07 (-0.05%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

CVSA stock chart

Technical analysis

Key statistics

All statistics
Ex-dividend date
Nov 30, 2016
52-week range
86.97 – 156.26
Day range
126.58 – 128.97
Volume / Avg
267.29K / 357.25K
Beta
—
Next earnings
Oct 29, 2026

52-week range

$86.97$156.26

CVSA stock today

Covista (CVSA) closed at $127.30 on Oct 7, down 0.05% (-$0.07), versus the S&P 500's 0.22% decline. Shares are 18.5% below their 52-week high of $156.26, set on Oct 24, 2025 and 46.4% above the 52-week low of $86.97, in the middle of the past year's range. CVSA is up 23.0% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 12.0%.

At 17.0x trailing earnings, Covista trades above the peer-group median of 14.6x. Its forward P/E of 12.7x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Covista's next earnings report is expected on Oct 29, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

About Covista

Company profile

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten.

Industry
Other Consumer Services
CEO
Mr. Stephen W. Beard J.D.
Headquarters
Chicago, IL
Employees
4,736

Financial highlights

Full financials

In fiscal 2026, Covista generated $1.95 billion in revenue, up 9.3% from fiscal 2025, its 6th consecutive year of revenue growth. Net income was $251.6 million (+6.1% year over year), for a net margin of 12.9% versus a median of 8.6% in the prior 5 years. Gross margin was 57.3% (up from 56.9%) and operating margin 19.6%.

Covista annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$1.95B$1.79B$1.58B$1.45B$1.38B
Growth+9.27%+12.85%+9.22%+4.99%+53.67%
Net income$251.57M$237.06M$136.78M$93.36M$310.99M
EPS (diluted)$7.04$6.18$3.39$2.05$6.43

Analyst forecast

Forecast

Consensus (4 analysts)

buy

Avg. price target

$158.75+24.71%

  • Strong buy 1
  • Buy 2
  • Hold 1
  • Sell 0
  • Strong sell 0

Target range

Low $140.00High $175.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Oct 29, 2026
EPS estimate
$1.90
Last reported (Q4 2026)
Aug 6, 2026
EPS actual vs est.
$2.06 vs —

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$0.18
Ex-dividend date
Nov 30, 2016

Covista peers

Real Estate sector
CVSA peer companies
CompanyPrice% ChgMarket capCompare
UNFUnifirst Corporation252.31+0.23%$4.56Bvs CVSA
LOPEGrand Canyon Education Inc.155.68+0.08%$4.06Bvs CVSA
GHCGraham Holdings Company1,169.60+1.03%$4.95Bvs CVSA
HRBH&R Block Inc.43.16+1.24%$5.29Bvs CVSA
LAURLaureate Education Inc.38.56+0.81%$5.31Bvs CVSA
LRNStride Inc.79.62-0.16%$3.31Bvs CVSA
BFAMBright Horizons Family Solutions Inc.66.84+0.63%$3.25Bvs CVSA
PRDOPerdoceo Education Corporation32.19+0.41%$2.01Bvs CVSA

Indexes, lists and sector

Covista stock FAQ

What is Covista's stock price today?

CVSA last traded at $127.30 as of Oct 7, 4:00 PM EDT, down 0.05% on the day. Prices are delayed at least 15 minutes.

Does Covista pay a dividend?

Yes. Covista pays $0.00 per share annually. The most recent dividend of $0.18 had an ex-dividend date of Nov 30, 2016.

When is Covista's next earnings date?

Covista is expected to report earnings on Thursday, October 29, 2026. Analysts expect EPS of $1.90.

What is CVSA's P/E ratio?

CVSA trades at a trailing P/E ratio of 17.00 and a forward P/E of 12.72, compared with a median of 14.6 for its closest peers.

Who is Covista's CEO?

Mr. Stephen W. Beard J.D. is the chief executive officer of Covista Inc., which has about 4,736 employees.

Has CVSA ever split its stock?

Yes. The most recent CVSA stock split was a 2-for-1 split on Jun 22, 1998, one of 3 splits on record.

What is the CVSA 52-week high?

The 52-week high for CVSA is $156.26 and the 52-week low is $86.97. The stock is currently 18.5% below its high.

Compare CVSA